Subclinical

Some conditions may remain subclinical until they resolve without intervention, whereas others worsen from subclinical to clinical status.

Off-label use of certain drugs at subclinical dosages has been a theme in realms of activity such as metabolic optimization, weight loss, body hacking, and neurohacking (e.g., nootropics); such drugs include metformin, beta-blockers, and others.